Febrile neutropenia in a HIV positive individual post-chemotherapy.
Ridha
E
E
Department of HIV Medicine, Chelsea and Westminster Hospital, 369 Fulham Road, London SW10 9NH, UK. essra.ridha@chelwest.nhs.uk
Cookson
H
H
Devitt
E
E
Nelson
M
M
D000971:Antineoplastic Combined Chemotherapy Protocols; D000998:Antiviral Agents / Q000627:therapeutic use; D003520:Cyclophosphamide; D003586:Cytomegalovirus Infections / Q000175:diagnosis / Q000188:drug therapy / Q000821:virology*; D004317:Doxorubicin; D005334:Fever / Q000097:blood / Q000150:complications* / Q000175:diagnosis; D017245:Foscarnet / Q000627:therapeutic use; D015658:HIV Infections / Q000097:blood / Q000150:complications*; D006801:Humans; D007150:Immunohistochemistry; D016483:Lymphoma, AIDS-Related / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000821:virology; D008297:Male; D008875:Middle Aged; D009336:Necrosis / Q000473:pathology / Q000821:virology; D009503:Neutropenia / Q000150:complications* / Q000175:diagnosis; D011241:Prednisone; D012867:Skin / Q000473:pathology / Q000821:virology; D013848:Thigh / Q000473:pathology / Q000821:virology; D014750:Vincristine
D000998:Antiviral Agents; D017245:Foscarnet; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone